FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 330:1789-1790 June 23, 1994 Number 25 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text Letters Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited PubMed Citation

Hereditary hemorrhagic telangiectasia (Rendu-Osler-Weber disease) is characterized by telangiectatic lesions of the nose, lips, and visceral organs including the liver, spleen, gastrointestinal tract, lungs, brain, and spinal cord^1,2,3,4,5. It is inherited as an autosomal dominant trait. Its most common manifestations are recurrent epistaxis and gastrointestinal bleeding, which can be life threatening⁶. Nasal bleeding has been treated by dermatoplasty of the nasal septa, photocoagulation, and amniotic-membrane grafts^6,7 and by the administration of estrogen and progesterone,^8,9 but these treatments are often ineffective.

Aminocaproic acid is a potent inhibitor of the fibrinolytic system. In low doses it blocks the conversion of . . . [Full Text of this Article]

Case Reports

Patient 1

Patient 2

Discussion

Source Information

From the Division of Medical Oncology and Hematology, H. Lee Moffitt Cancer Center and Research Institute, University of South Florida College of Medicine (H.I.S., L.A.L.), and James A. Haley Veterans Hospital (H.I.S., G.A.M., L.A.L.) -- both in Tampa, Fla.

Address reprint requests to Dr. Saba at the Division of Medical Oncology and Hematology, H. Lee Moffitt Cancer Center and Research Institute, 12902 Magnolia Dr., Tampa, FL 33612.

References

Related Letters:

Treatment of Bleeding in Hereditary Hemorrhagic Telangiectasia with Aminocaproic Acid
Korzenik J. R., Topazian M. D., White R., Saba H. I., Morelli G., Logrono L.
Extract | Full Text  
N Engl J Med 1994; 331:1236, Nov 3, 1994. Correspondence

This article has been cited by other articles:

• Sabba, C., Pasculli, G., Suppressa, P., D'Ovidio, F., Lenato, G. M., Resta, F., Assennato, G., Guanti, G. (2006). Life expectancy in patients with hereditary haemorrhagic telangiectasia. QJM 99: 327-334 [Abstract] [Full Text]  
• Begbie, M E, Wallace, G M F, Shovlin, C L (2003). Hereditary haemorrhagic telangiectasia (Osler-Weber-Rendu syndrome): a view from the 21st century. Postgrad. Med. J. 79: 18-24 [Abstract] [Full Text]  
• Ghosh, S, Watts, D, Kinnear, M (2002). Management of gastrointestinal haemorrhage. Postgrad. Med. J. 78: 4-14 [Abstract] [Full Text]  
• Sabba, C., Gallitelli, M., Palasciano, G. (2001). Efficacy of Unusually High Doses of Tranexamic Acid for the Treatment of Epistaxis in Hereditary Hemorrhagic Telangiectasia. NEJM 345: 926-926 [Full Text]  
• Klepfish, A., Berrebi, A., Schattner, A. (2001). Intranasal Tranexamic Acid Treatment for Severe Epistaxis in Hereditary Hemorrhagic Telangiectasia. Arch Intern Med 161: 767-767 [Full Text]  
• Shovlin, C. L, Letarte, M. (1999). Rare diseases bullet 4: Hereditary haemorrhagic telangiectasia and pulmonary arteriovenous malformations: issues in clinical management and review of pathogenic mechanisms. Thorax 54: 714-729 [Full Text]  
• Colletti, R. B., Compton, C. C. (1997). Case 7-1997- A 14-Year-Old Girl with Recurrent Painless Rectal Bleeding. NEJM 336: 641-649 [Full Text]  
• Korzenik, J. R., Topazian, M. D., White, R., Saba, H. I., Morelli, G., Logrono, L. (1994). Treatment of Bleeding in Hereditary Hemorrhagic Telangiectasia with Aminocaproic Acid. NEJM 331: 1236-1236 [Full Text]  
• (1994). Hereditary Hemorrhagic Telangiectasia Treated with Aminocaproic Acid. Journal Watch Dermatology 1994: 2-2 [Full Text]  
• Phillips, M. D. (1994). Stopping Bleeding in Hereditary Telangiectasia. NEJM 330: 1822-1823 [Full Text]